rs2005698
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_004598.4(SPOCK1):c.186+107311G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.327 in 151,782 control chromosomes in the GnomAD database, including 8,198 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.33 ( 8198 hom., cov: 31)
Consequence
SPOCK1
NM_004598.4 intron
NM_004598.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.86
Publications
0 publications found
Genes affected
SPOCK1 (HGNC:11251): (SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1) This gene encodes the protein core of a seminal plasma proteoglycan containing chondroitin- and heparan-sulfate chains. The protein's function is unknown, although similarity to thyropin-type cysteine protease-inhibitors suggests its function may be related to protease inhibition. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.419 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SPOCK1 | ENST00000394945.6 | c.186+107311G>T | intron_variant | Intron 2 of 10 | 1 | NM_004598.4 | ENSP00000378401.1 | |||
| SPOCK1 | ENST00000505690.1 | c.186+107311G>T | intron_variant | Intron 1 of 3 | 2 | ENSP00000424517.1 | ||||
| SPOCK1 | ENST00000510689.5 | c.-250+108117G>T | intron_variant | Intron 1 of 5 | 4 | ENSP00000421677.1 | ||||
| SPOCK1 | ENST00000503916.1 | n.251+114577G>T | intron_variant | Intron 2 of 4 | 4 |
Frequencies
GnomAD3 genomes AF: 0.327 AC: 49616AN: 151664Hom.: 8173 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
49616
AN:
151664
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.327 AC: 49673AN: 151782Hom.: 8198 Cov.: 31 AF XY: 0.330 AC XY: 24486AN XY: 74186 show subpopulations
GnomAD4 genome
AF:
AC:
49673
AN:
151782
Hom.:
Cov.:
31
AF XY:
AC XY:
24486
AN XY:
74186
show subpopulations
African (AFR)
AF:
AC:
12283
AN:
41342
American (AMR)
AF:
AC:
6529
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
AC:
1093
AN:
3466
East Asian (EAS)
AF:
AC:
1527
AN:
5132
South Asian (SAS)
AF:
AC:
1885
AN:
4796
European-Finnish (FIN)
AF:
AC:
3442
AN:
10532
Middle Eastern (MID)
AF:
AC:
101
AN:
294
European-Non Finnish (NFE)
AF:
AC:
21906
AN:
67930
Other (OTH)
AF:
AC:
771
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1707
3414
5121
6828
8535
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
502
1004
1506
2008
2510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1353
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.